Patents by Inventor Evelina VÅGESJÖ

Evelina VÅGESJÖ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230093013
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Application
    Filed: August 11, 2022
    Publication date: March 23, 2023
    Inventor: Evelina VÅGESJÖ
  • Patent number: 11473091
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: October 18, 2022
    Assignee: ILYA PHARMA AB
    Inventor: Evelina Vågesjö
  • Patent number: 11414668
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: August 16, 2022
    Assignee: ILYA PHARMA AB
    Inventor: Evelina Vågesjö
  • Publication number: 20200299703
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Application
    Filed: June 5, 2020
    Publication date: September 24, 2020
    Inventor: Evelina VÅGESJÖ
  • Patent number: 10696974
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Grant
    Filed: December 23, 2015
    Date of Patent: June 30, 2020
    Assignee: ILYA PHARMA AB
    Inventor: Evelina Vågesjö
  • Publication number: 20180187202
    Abstract: The invention relates to plasmids capable of expressing a protein targeting immune cells when transformed into a lactic acid bacterial cell, wherein the protein is chosen from the group consisting of murine and human CXCL12 1?; CXCL17 and Ym1. The invention further relates to lactic acid bacteria transformed with a said plasmid, as well as the use of said lactic acid bacteria for wound healing in humans and animals.
    Type: Application
    Filed: December 23, 2015
    Publication date: July 5, 2018
    Inventor: Evelina VÅGESJÖ